Registrer deg | Logg på | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

ndoelkers chemokine [25 articles]

Artikler nylig sendt til ndoelkers bibliotek klassifisert med nøkkelordet chemokine. You can also see everyone's chemokine.
  • Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.
    Biochemistry, Vol. 41, No. 46. (19 November 2002), pp. 13548-13555.
    by A Bondue, SC Jao, C Blanpain, M Parmentier, PJ LiWang
    posted to chemokine ccr5 binding by ndoelker on 2007-01-20 15:08:17 as *** along with 1 group LabCompMed
  • A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.
    Proc Natl Acad Sci U S A, Vol. 96, No. 10. (May 1999), pp. 5698-703.
  • The core domain of chemokines binds CCR5 extracellular domains while their amino terminus interacts with the transmembrane helix bundle.
    J Biol Chem, Vol. 278, No. 7. (Feb 2003), pp. 5179-87.
    by Cã©dric Blanpain, Benjamin J Doranz, Antoine Bondue, Cã©dric Govaerts, Anne De Leener, Gilbert Vassart, Robert W Doms, Amanda Proudfoot, Marc Parmentier
  • Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
    J Biol Chem, Vol. 275, No. 31. (Aug 2000), pp. 23736-44.
    by A Brelot, N Heveker, M Montes, M Alizon
  • Mutagenesis of CXCR4 identifies important domains for human immunodeficiency virus type 1 X4 isolate envelope-mediated membrane fusion and virus entry and reveals cryptic coreceptor activity for R5 isolates.
    J Virol, Vol. 73, No. 8. (Aug 1999), pp. 6598-609.
    by DJ Chabot, PF Zhang, GV Quinnan, CC Broder
    posted to bibtex-nicole chemokine cxcr4 gpcr by ndoelker on 2006-10-30 16:53:03 as read along with 1 group LabCompMed
  • Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors.
    J Med Chem, Vol. 46, No. 21. (Oct 2003), pp. 4501-15.
    by Asim K Debnath
  • A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5.
    Proc Natl Acad Sci U S A, Vol. 97, No. 10. (May 2000), pp. 5639-44.
    by T Dragic, A Trkola, DA Thompson, EG Cormier, FA Kajumo, E Maxwell, SW Lin, W Ying, SO Smith, TP Sakmar, JP Moore
  • Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor.
    J Biol Chem, Vol. 276, No. 17. (Apr 2001), pp. 14153-60.
    by LO Gerlach, RT Skerlj, GJ Bridger, TW Schwartz
  • Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.
    Biochemistry, Vol. 42, No. 3. (Jan 2003), pp. 710-7.
    by Lars O Gerlach, Janus S Jakobsen, Kasper P Jensen, Mette R Rosenkilde, Renato T Skerlj, Ulf Ryde, Gary J Bridger, Thue W Schwartz
  • The TXP motif in the second transmembrane helix of CCR5. A structural determinant of chemokine-induced activation.
    J Biol Chem, Vol. 276, No. 16. (Apr 2001), pp. 13217-13225.
  • Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3.
    J Biol Chem, Vol. 278, No. 3. (Jan 2003), pp. 1892-903.
    by Cã©dric Govaerts, Antoine Bondue, Jean Y Springael, Mireia Olivella, Xavier Deupi, Emmanuel Le Poul, Shoshana J Wodak, Marc Parmentier, Leonardo Pardo, Cã©dric Blanpain
  • Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
    Mol Pharmacol, Vol. 60, No. 1. (Jul 2001), pp. 164-73.
  • Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.
    J Virol, Vol. 77, No. 2. (Jan 2003), pp. 931-42.
    by George Lin, Frã©dã©ric Baribaud, Josephine Romano, Robert W Doms, James A Hoxie
  • Five-transmembrane domains appear sufficient for a G protein-coupled receptor: functional five-transmembrane domain chemokine receptors.
    Proc Natl Acad Sci U S A, Vol. 96, No. 14. (Jul 1999), pp. 7922-7927.
    by K Ling, P Wang, J Zhao, YL Wu, ZJ Cheng, GX Wu, W Hu, L Ma, G Pei
  • Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5.
    J Biol Chem, Vol. 276, No. 37. (Sep 2001), pp. 35194-200.
  • International union of pharmacology. XXII. Nomenclature for chemokine receptors
    PHARMACOLOGICAL REVIEWS, Vol. 52, No. 1. (2000), pp. 145-176.
    by PM Murphy, M Baggiolini, IF Charo, CA Hebert, R Horuk, K Matsushima, LH Miller, JJ Oppenheim, CA Power
  • Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    J Mol Biol, Vol. 313, No. 5. (Nov 2001), pp. 1181-93.
    by JM Navenot, ZX Wang, JO Trent, JL Murray, QX Hu, L Deleeuw, PS Moore, Y Chang, SC Peiper
  • Chemokines, chemokine receptors and small-molecule antagonists: recent developments.
    Trends Pharmacol Sci, Vol. 23, No. 10. (Oct 2002), pp. 459-67.
    by James J Onuffer, Richard Horuk
  • Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity.
    Biophys J, Vol. 83, No. 6. (Dec 2002), pp. 3012-31.
    by Germana M Paterlini
  • SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo.
    Proc Natl Acad Sci U S A, Vol. 98, No. 22. (Oct 2001), pp. 12718-23.
    by JM Strizki, S Xu, NE Wagner, L Wojcik, J Liu, Y Hou, M Endres, A Palani, S Shapiro, JW Clader, WJ Greenlee, JR Tagat, S Mccombie, K Cox, AB Fawzi, CC Chou, Pugliese C Sivo, L Davies, ME Moreno, DD Ho, A Trkola, CA Stoddart, JP Moore, GR Reyes, BM Baroudy
  • Identification of a signal transduction switch in the chemokine receptor CXCR1.
    J Biol Chem, Vol. 277, No. 35. (Aug 2002), pp. 31563-6.
    by Katsutoshi Suetomi, Daniel Rojo, Javier Navarro
  • Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.
    J Med Chem, Vol. 47, No. 10. (May 2004), pp. 2405-8.
    by Jayaram R Tagat, Stuart W Mccombie, Dennis Nazareno, Marc A Labroli, Yushi Xiao, Ruo W Steensma, Julie M Strizki, Bahige M Baroudy, Kathleen Cox, Jean Lachowicz, Geoffrey Varty, Robert Watkins
  • Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Bioorg Med Chem, Vol. 12, No. 23. (Dec 2004), pp. 6193-208.
    by Yong Xu, Hong Liu, Chunying Niu, Cheng Luo, Xiaomin Luo, Jianhua Shen, Kaixian Chen, Hualiang Jiang
  • Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding.
    Arch Biochem Biophys, Vol. 373, No. 1. (Jan 2000), pp. 211-7.
    by H Zhou, HH Tai
  • Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction.
    Eur J Immunol, Vol. 30, No. 1. (Jan 2000), pp. 164-73.
    by N Zhou, Z Luo, JW Hall, J Luo, X Han, Z Huang
  • NB: Du kan sitere denne siden som: http://www.citeulike.org/user/ndoelker/tag/chemokine

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.